Skip to content

News Archives

The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.

photo of the author, C. Michael White

Pharmacy professor: buying prescription drugs from Canada “risky in terms of quality and safety”

September 27, 2019

This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.

Partnership for Safe Medicines 2019 Congressional Briefings (September 24, 2019)

September 24, 2019

On Tuesday, September 24, 2019, counterfeit medication victims and their families, American and Canadian patient groups, local and federal law enforcement, and other experts in the fight against counterfeit medicines gathered in Washington, D.C. to discuss how importation proposals threaten to trigger drug shortages in Canada while wreaking havoc on medication safety for U.S. patients.

Deaths from Counterfeit Pills in Alaska, California, and Washington

September 23, 2019

Virtually every state in the Union has a serious problem with counterfeit pills made with fentanyl. During the month of September we have found reports of counterfeit pill deaths in Alaska, California, and Washington.

Idaho Doctor Admits Putting Counterfeit Breast Implants from China in Nine Patients

September 19, 2019

A medical doctor in Burley, Idaho has pleaded guilty to charges he used illegally imported breast implants from China on nine patients in his care. Dr. Temp Ray Patterson has admitted in court that he misled his patients by telling them the breast implants were FDA-approved; when he knew for a fact they were not.

Vitamin C liquid supplement Recalled due to Contamination with Prescription Drug Tadalafil

September 16, 2019

Fitoterapia USA Inc., is voluntarily recalling 19,000 bottles of MACHO ARTIFICIAL PASSION FRUIT FLAVORED VITAMIN C LIQUID SUPPLEMENT, liquid dietary supplement to the consumer level. FDA analysis has found the product to be tainted with Tadalafil.

Former FDA Associate Commissioner Says Canada Cannot Be America’s Pharmacy

September 12, 2019

This editorial by Peter J. Pitts was published in The Washington Times on September 11, 2019. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner.

Utah’s Eagle Scout Turned Fake Pill Seller Convicted on Drug Distribution Charges

September 11, 2019

The Department of Justice (DOJ) has announced that Aaron Michael Shamo, 29 has been found guilty by a jury of organizing and directing a drug trafficking organization that ordered imported fentanyl and alprazolam online from China and used the drugs to press fake oxycodone pills made with fentanyl and counterfeit Xanax tablets.

LA City Attorney Files Charges in 2 Different Counterfeit/Misbranded Prescription Drug Cases

September 6, 2019

On August 21, LA City Attorney Mike Feuer announced two separate cases had resulted in charges. In the first, criminal charges have been filed against eight people for allegedly importing more than 100,000 units of non-FDA approved pharmaceuticals, and selling them in the local area on the street in front of local businesses. In a second case, Feuer’s office seized a website offering illegal, misbranded, and counterfeit medications for sale online.

Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab

August 30, 2019

AmEx Pharmacy today announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable that are within expiry to the healthcare provider level. These lots are being recalled out of an abundance of caution following an FDA inspection.

Economic Policy Researcher Finds Fault with Federal Drug Importation Plans

August 30, 2019

This editorial by Liam Sigaud was published by Inside Sources on August 27, 2019. Mr. Sigaud is an economic policy researcher who writes for the American Consumer Institute, a nonprofit educational and research organization.

Scroll To Top